Loading...

Pasithea Therapeutics Corp.

KTTAW•NASDAQ
Healthcare
Biotechnology
$0.02
$0.005(31.25%)

Pasithea Therapeutics Corp. (KTTAW) Stock Overview

Explore Pasithea Therapeutics Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.2/100

Key Financials

Market Cap156.3K
P/E Ratio-0.12
EPS (TTM)N/A
ROE-0.00%

AI Price Forecasts

1 Week$0.02
1 Month$0.02
3 Months$0.00
1 Year Target$0.00

KTTAW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pasithea Therapeutics Corp. (KTTAW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.12 and a market capitalization of 156.3K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for KTTAWStats details for KTTAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for KTTAWAnalyst Recommendations details for KTTAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.

CEO

Tiago Reis Marques

Employees

4

Headquarters

1111 Lincoln Road, Miami Beach, FL

Founded

2021

Frequently Asked Questions

;